BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 6056907)

  • 1. The blood flow in calf muscles in normal man and in patients with obliterative arterial disease studied during walking by the Xe-133 clearance method.
    García del Río H
    Scand J Clin Lab Invest Suppl; 1967; 99():130-2. PubMed ID: 6056907
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine use of the xenon-133 clearance method in peripheral circulation studies, with special regard to its correlation to angiography.
    Lindbjerg IF
    Scand J Clin Lab Invest Suppl; 1967; 99():123-9. PubMed ID: 6056906
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of the measurement of the muscle blood flow in the extremities using 133Xe.
    Galus K
    Pol Med J; 1969; 8(5):1069-77. PubMed ID: 4911163
    [No Abstract]   [Full Text] [Related]  

  • 4. Plethysmographic measurements of calf blood flow, and Xe-133 clearance from the calf muscle in patients with intermittent claudication.
    Hlavová A; Linhart J; Prerovský I; Oppelt A; Vavrejn B
    Cor Vasa; 1968; 10(2):99-109. PubMed ID: 5706099
    [No Abstract]   [Full Text] [Related]  

  • 5. 133-Xenon tests for evaluating obliterative arterial disease.
    Lindbjerg IF
    Scand J Clin Lab Invest Suppl; 1967; 100():77. PubMed ID: 6038157
    [No Abstract]   [Full Text] [Related]  

  • 6. The measurement of blood flow through muscle from the clearance of radioactive xenon.
    Bell G; Short DW
    Surg Gynecol Obstet; 1968 Jul; 127(1):61-5. PubMed ID: 5657783
    [No Abstract]   [Full Text] [Related]  

  • 7. On the estimation of local effective perfusion pressure in patients with obliterative arterial disease by means of external compression over a Xenon-133 depot.
    Nilsén R; Dahn I; Lassen NA; Westling H
    Scand J Clin Lab Invest Suppl; 1967; 99():29-30. PubMed ID: 6056929
    [No Abstract]   [Full Text] [Related]  

  • 8. Exercise blood flow by 133-xenon clearance in claudicating patients: reproducibility and sensitivity of the method in comparison to angiography, venous occlusion plethysmography, and walking distance on escalator.
    Tennesen KH
    Scand J Clin Lab Invest Suppl; 1967; 100():84. PubMed ID: 6038159
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use of Xe-133 non-ischemic work method in obliterative arterial diseases of the legs.
    Hirai M; Shionoya S
    Jpn Circ J; 1974 Sep; 38(9):763-74. PubMed ID: 4431094
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple, objective test for arteriosclerosis obliterans.
    Coffman JD; Mannick JA
    N Engl J Med; 1965 Dec; 273(24):1297-301. PubMed ID: 5852453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative measurements of muscle blood flow using vein occlusion plethysmography and 133 xenon clearance in arteriosclerosis obliterans].
    Mörl H; Gabriel R; Bartusch M
    Z Kreislaufforsch; 1971 May; 60(5):447-51. PubMed ID: 5557743
    [No Abstract]   [Full Text] [Related]  

  • 12. Xenon-133 clearance studies during walking; effect on muscle and skin blood flow; routine application with comment on branch thrombosis below the knee.
    Larsen OA
    Scand J Clin Lab Invest Suppl; 1973; 128():89-92. PubMed ID: 4587558
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measurement of muscle perfusion in the lower extremities using the local xenon 133 clearance method. II. Diagnosis of arterial obliterations].
    Kuchar O; Kuba J; Tomsů M
    Radiol Diagn (Berl); 1972; 13(2):225-31. PubMed ID: 5046289
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measurement of muscle perfusion in the lower extremities using the local xenon 133 clearance method. II. Diagnosis of arterial obliterations].
    Kuchar O; Kuba J; Tomsů M
    Radiobiol Radiother (Berl); 1972; 13(2):225-31. PubMed ID: 4636559
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioactive xenon tissue clearance: standardization for measurement of peripheral blood flow.
    Corman LA; Flickinger FW; Sokoloff J; Nodine JH
    J Nucl Med; 1970 Jun; 11(6):233-8. PubMed ID: 4393045
    [No Abstract]   [Full Text] [Related]  

  • 16. Capillary diffusion capacity of sodium studied by the clearances of Na-24 and Xe-133 from hyperemic skeletal muscle in man.
    Lassen NA
    Scand J Clin Lab Invest Suppl; 1967; 99():24-6. PubMed ID: 6056928
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood flow in the calf muscles during walking: effect of daily muscular exercise in patients with occlusive arterial disease.
    Alpert J; Larsen OA; Lassen NA
    Scand J Clin Lab Invest Suppl; 1967; 100():90. PubMed ID: 6038162
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscle blood flow measured by XE-133 clearance method and peripheral vascular diseases. Part 2. Normals and patients with peripheral vascular diseases.
    Hirai M
    Jpn Circ J; 1974 Aug; 38(8):661-6. PubMed ID: 4421741
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical performance capacity in patients with dysbasia arteriosclerotica. 3. Blood flow in the legs measured by venous occlusion plethysmography and 133Xe clearance correlated to bicycle ergometry.
    Bonde-Petersen F; Siggaard-Andersen J
    Scand J Rehabil Med; 1974; 6(1):31-5. PubMed ID: 4826162
    [No Abstract]   [Full Text] [Related]  

  • 20. Exercise and intermittent claudication. Blood flow in the calf muscle during walking studied by the xenon-133 clearance method.
    Alpert JS; Larsen OA; Lassen NA
    Circulation; 1969 Mar; 39(3):353-9. PubMed ID: 4885945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.